The exact disease pathogenesis is unknown; however, the presence of type I IFN, B cell-activating factor (BAFF), and IL-12 indicate an interaction between innate and adaptive immune responses in SS pathogenesis. This evidence concerns the gene TNFSF13B and synovial sarcoma.